A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Disease
Conditions
- Moderate to Severe Alzheimer
Interventions
- DRUG: Dimebon (latrepirdine)
- DRUG: Placebo
Sponsor
Medivation, Inc.
Collaborators